Does the MetLife decision change the way US regulators should be thinking about systemic risk? Should UK regulators, post-Brexit, be reconsidering their systemic risk regulatory regime as well?
A bit of comparative analysis, like this, might help us think about these questions.Across the EU, the US and (at least until the impact of Brexit is felt)...
